Tejal Mehta Lab
Modified and site‑specific drug delivery systems
The group designs micro- and nanocarrier formulations for the oral cavity, the eye, the skin and the vaginal route, and improves the dissolution of poorly soluble drugs.
Prof. Tejal MehtaProfessor and Head, Department of Pharmaceutics
Where a dose goes
Each route asks something different of a formulation: stay put in the mouth, get past the surface of the eye, hold a drug in the skin, cling to mucosa, or wait until the colon. Five stops, with the group's papers for each.
-
1 of 5
Mouth
Erlotinib liposomal gel for oral squamous cell carcinoma; electrospun nanofibres for locoregional therapy.
55.27%tumour volume reduction in vivo with chitosan-coated erlotinib liposomal gel, against 38.88% for plain erlotinib gel.
- Localized delivery of erlotinib using liposomal gel formulations for the treatment of oral squamous cell carcinoma2023, Int J Pharm
Liposomal gel
- Gel base, applied locally in the mouth
- Liposome: drug inside a lipid bilayer
- Dashed ring: chitosan coat
-
2 of 5
Eye
Drug nanocrystals, mesoporous silica nanoparticles, long-acting implants for macular degeneration.
- Next-generation drug delivery for age-related macular degeneration: promise of controlled release formulations2026 review, Drug Dev Ind Pharm
- Mesoporous silica nanoparticles for ocular drug delivery: synthesis, functionalization, and safety insights2026 review, AAPS PharmSciTech
Mesoporous silica and nanocrystal
- Silica particle: drug held in its pores
- Drug nanocrystal: the drug itself, milled to nanometre size
-
3 of 5
Skin
Tacrolimus nanoparticle hydrogel, clotrimazole lipid nanogel, betamethasone nanocrystals, silver nanoparticle wound film.
7-foldhigher water solubility of tacrolimus in phosphonate-functionalised mesoporous silica nanoparticles than free drug.
- Tacrolimus encapsulated mesoporous silica nanoparticles embedded hydrogel for the treatment of atopic dermatitis2021, Int J Pharm
- Quality by design driven development of lipid nanoparticles for cutaneous targeting2024, Drug Deliv Transl Res
- Betamethasone dipropionate nanocrystals: investigation, feasibility and in vitro evaluation2022, AAPS PharmSciTech
- Formulation of chitosan stabilized silver nanoparticle-containing wound healing film2020, J Pharm Sci
Nanoparticle hydrogel on skin
- Hydrogel layer with drug-loaded nanoparticles
- Outer skin layers, where the drug is meant to stay
-
4 of 5
Vaginal route
Clotrimazole mucoadhesive film; 3D-printed delivery systems.
- Formulation, development and characterization of mucoadhesive film for treatment of vaginal candidiasis2016, Int J Pharm Investig
- Vaginal drug delivery for precision therapy in polyendocrine metabolic ovarian syndrome2026 review, Expert Opin Drug Deliv
Mucoadhesive film
- Thin film carrying dispersed drug
- Mucosal surface the film adheres to
-
5 of 5
Gut and under the tongue
Colon, stomach, sublingual, and nose to brain.
7.2 hfor complete release from the colon-targeted metronidazole mini-tablets, with 6.99% released in the first 5 hours.
- Design of experiment approach for formulating multi-unit colon-targeted drug delivery system2015, Drug Dev Ind Pharm
- Formulation optimization of gastroretentive drug delivery system for allopurinol using experimental design2014, Expert Opin Drug Deliv
- Development and optimization of asenapine sublingual film using QbD approach2021, AAPS PharmSciTech
Coated mini-tablets
- Thick outline: coating that holds back release
- Inner core: the drug-loaded mini-tablet
Funded project, ongoing
Formulation and development of nanofibers using electrospinning technique for locoregional therapy for oral cancer
Treating early oral cancer at the site of the tumour, so that less drug reaches healthy tissue. The group's earlier work loaded erlotinib into liposomes and a gel for local application in the mouth; the current project builds electrospun nanofibre systems for the same purpose.
- Grant
- ≈ ₹57 lakh
- Funder
- GSBTM, major research project
- Project
- Nanofiber-based drug delivery system for oral cancer
- Status
- Ongoing
Localized delivery of erlotinib using liposomal gel formulations for the treatment of oral squamous cell carcinomaHariharan K, Mehta T, Shah J, Dave H, Sami A, Omri A. Int J Pharm 642, 123144 (2023)
Tumour volume reduction in vivo
Erlotinib gels applied locally, compared by formulation
- Plain erlotinib gel38.88%
- Erlotinib liposomal gel49.19%
- Chitosan-coated erlotinib liposomal gel55.27%
Publications
Prof. Mehta's faculty profile reports more than 100 research papers. PubMed indexes 38 of them with a Nirma University affiliation. Fourteen are listed here, placed on the years they appeared.
Grey column: papers PubMed indexes that year, out of a peak of 5 in 2021Marks: the papers listed on this page
Select a mark to see the paper.
- 2026, reviewVaginal drug delivery for precision therapy in polyendocrine metabolic ovarian syndromeShah S, Parikh A, Garg S, Mehta T. Expert Opin Drug Deliv 23, 1967-1990
- 2026, reviewNext-generation drug delivery for age-related macular degeneration: promise of controlled release formulationsBangar P, Garkal A, Mehta T. Drug Dev Ind Pharm 52, 1686-1699
- 2026, reviewMesoporous silica nanoparticles for ocular drug delivery: synthesis, functionalization, and safety insightsPatel L, Mehta T. AAPS PharmSciTech 27(4)
- 2024Quality by design driven development of lipid nanoparticles for cutaneous targetingPatel V, Mehta T, Shah J, Soni K. Drug Deliv Transl Res 15, 1393-1410
- 2023Localized delivery of erlotinib using liposomal gel formulations for the treatment of oral squamous cell carcinomaHariharan K, Mehta T, Shah J, Dave H, Sami A, Omri A. Int J Pharm 642, 123144
- 2022Betamethasone dipropionate nanocrystals: investigation, feasibility and in vitro evaluationPatel V, Mehta TA. AAPS PharmSciTech 23, 197
- 2021Development and optimization of asenapine sublingual film using QbD approachDalal R, Shah J, Gorain B, et al., Mehta TA. AAPS PharmSciTech 22, 244
- 2021Tacrolimus encapsulated mesoporous silica nanoparticles embedded hydrogel for the treatment of atopic dermatitisParekh K, Hariharan K, Qu Z, et al., Mehta T. Int J Pharm 608, 121079
- 2020Formulation of chitosan stabilized silver nanoparticle-containing wound healing filmPansara C, Mishra R, Mehta T, Parikh A, Garg S. J Pharm Sci 109, 2196-2205
- 2020Improvement of oral bioavailability of carvedilol by liquisolid compactJhaveri M, Nair AB, Shah J, Jacob S, Patel V, Mehta T. Drug Deliv Transl Res 10, 975-985
- 2019Impact of process parameters on particle size in media milling for clotrimazole nanocrystalsPatel V, Sharma OP, Mehta TA. AAPS PharmSciTech 20, 175
- 2016Formulation, development and characterization of mucoadhesive film for treatment of vaginal candidiasisMishra R, Joshi P, Mehta T. Int J Pharm Investig 6, 47-55
- 2015Design of experiment approach for formulating multi-unit colon-targeted drug delivery systemShah N, Sharma OP, Mehta T, Amin A. Drug Dev Ind Pharm 42, 825-835
- 2014Formulation optimization of gastroretentive drug delivery system for allopurinol using experimental designSharma OP, Shah MV, Parikh DC, Mehta TA. Expert Opin Drug Deliv 12, 513-524

Prof. Tejal Mehta
Professor and Head, Department of Pharmaceutics Deputy Director, Internal Quality Assurance Cell, Nirma University PhD, Sardar Patel University, Vallabh Vidyanagar. M.Pharm and B.Pharm, Gujarat University, Ahmedabad
- years of teaching, including research, at UG and PG level
- 27+
- research papers in national and international journals
- 100+
- chapters in national and international books
- 15+
- patents filed, 3 of them granted
- 5
- PhD scholars guided
- 20
Books
- Practical Manual of Pharmaceutical Engineering1st and 2nd editions
- Practical Manual of Pharmaceutical Dosage Forms
- Pharmaceutical Quality Management and Drug Delivery System
- An Essential Guide in Pharmaceutics
Awards
- Best Paper Award 2004Association of Pharmaceutical Teachers of India
- R. V. Patel Best M.Pharm Thesis AwardGuide category
- Best Professor Award for Overall PerformanceNirma University
- Long Service AwardNirma University
- Prof. M. L. Shroff Pharma Recognition AwardTeam Pharma Lok
Funded research
- Nanofiber-based drug delivery system for oral cancerGSBTM, major, approx. ₹57 lakhOngoing
- Minor research projectGUJCOST, amount not statedCompleted
Record, books, projects and awards as stated on the Institute of Pharmacy faculty profile, read 17 November 2026.
People
Current members of the group, each pursuing a PhD with Prof. Mehta in the Department of Pharmaceutics.
- Anam SamiPhD scholar
- Lajja PatelPhD scholar
- Shailvi ShahPhD scholar
- Priya PatelPhD scholar
- Priyam ThakarPhD scholar
Join the group
Prof. Mehta is a recognised PG and PhD guide of Nirma University. Twenty PhD scholars have completed their research with her. Students interested in M.Pharm or PhD research in pharmaceutics can contact her at the department.
- Telephone
- 079 7165 2716
- Office
- PG Faculty area, PG-204
- Address
- Institute of Pharmacy, Nirma University, Sarkhej-Gandhinagar Highway, Ahmedabad 382481